Business Description
Icon PLC
NAICS : 541380
SIC : 8734
ISIN : IE0005711209
Share Class Description:
ICLR: ADRDescription
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 2.25 | |||||
| Interest Coverage | 4.74 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.38 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.2 | |||||
| 3-Year EBITDA Growth Rate | 28.6 | |||||
| 3-Year EPS without NRI Growth Rate | 8.7 | |||||
| 3-Year FCF Growth Rate | 7.6 | |||||
| 3-Year Book Growth Rate | 47.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 24.28 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.54 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.46 | |||||
| 9-Day RSI | 57.28 | |||||
| 14-Day RSI | 49.68 | |||||
| 6-1 Month Momentum % | -32.38 | |||||
| 12-1 Month Momentum % | -23.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.34 | |||||
| Quick Ratio | 1.34 | |||||
| Cash Ratio | 0.25 | |||||
| Days Sales Outstanding | 74.42 | |||||
| Days Payable | 6.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16 | |||||
| Shareholder Yield % | 4.77 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.58 | |||||
| Operating Margin % | 13.77 | |||||
| Net Margin % | 9 | |||||
| FCF Margin % | 14.79 | |||||
| ROE % | 7.96 | |||||
| ROA % | 4.39 | |||||
| ROIC % | 6.44 | |||||
| ROC (Joel Greenblatt) % | 208.32 | |||||
| ROCE % | 7.38 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.41 | |||||
| Forward PE Ratio | 14.3 | |||||
| PE Ratio without NRI | 14.97 | |||||
| Shiller PE Ratio | 32.77 | |||||
| Price-to-Owner-Earnings | 16.37 | |||||
| PEG Ratio | 0.83 | |||||
| PS Ratio | 2.1 | |||||
| PB Ratio | 1.77 | |||||
| Price-to-Free-Cash-Flow | 14.21 | |||||
| Price-to-Operating-Cash-Flow | 12.57 | |||||
| EV-to-EBIT | 19.1 | |||||
| EV-to-Forward-EBIT | 14.74 | |||||
| EV-to-EBITDA | 12.59 | |||||
| EV-to-Forward-EBITDA | 11.82 | |||||
| EV-to-Revenue | 2.41 | |||||
| EV-to-Forward-Revenue | 2.38 | |||||
| EV-to-FCF | 16.29 | |||||
| Price-to-Projected-FCF | 1.02 | |||||
| Price-to-DCF (Earnings Based) | 0.65 | |||||
| Price-to-DCF (FCF Based) | 0.53 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.68 | |||||
| Earnings Yield (Greenblatt) % | 5.24 | |||||
| FCF Yield % | 7.09 | |||||
| Forward Rate of Return (Yacktman) % | 24.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ICLR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Icon PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8,306.823 | ||
| EPS (TTM) ($) | 8.97 | ||
| Beta | 1.39 | ||
| Volatility % | 40.9 | ||
| 14-Day RSI | 49.68 | ||
| 14-Day ATR ($) | 7.074103 | ||
| 20-Day SMA ($) | 210.841 | ||
| 12-1 Month Momentum % | -23.65 | ||
| 52-Week Range ($) | 183.38 - 347.7225 | ||
| Shares Outstanding (Mil) | 82.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Icon PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Icon PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Icon PLC Frequently Asked Questions
What is Icon PLC(ICLR)'s stock price today?
The current price of ICLR is $213.26. The 52 week high of ICLR is $347.72 and 52 week low is $183.38.
When is next earnings date of Icon PLC(ICLR)?
The next earnings date of Icon PLC(ICLR) is 2025-02-21 Est..
Does Icon PLC(ICLR) pay dividends? If so, how much?
Icon PLC(ICLR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers